Table 9.
Anti-inflammatory activity of components from A. pilosa.
A. pilosa extract | Experimental model | Test dose range | Contrast | Route of administration | Pharmacological action | Mechanism of action | References |
---|---|---|---|---|---|---|---|
Agrimonolide | LPS-induced RAW 264.7 cells | 0, 20, 40, 60, 80 μg/ml | Negative control | NS | Anti-inflammatory | NO scavenging, COX-2/inos↓, NF-κB ↓, MAPKs↓, JAK-STATs↓ | [35] |
Agrimonolide-6-O-β-D-glucopyranoside | LPS-induced RAW 264.7 cells | 50, 100, 200 μg/ml | 4-Ethyl-2-hydroxyamino-5-nitro-3-hexenamide (200 μM) | NS | NO scavenging | NS | [47] |
Agrimonolide-6-O-β-D-glucopyranoside | LPS-induced RAW 264.7 cells | 25, 50, 100 μg/ml | Negative control | NS | NO production decreasing | NS | [35] |
Pilosanol N | LPS/IFN-γ-induced RAW264.7 macrophages | 25, 50, 100 μg/ml | NOR3 (200 μM) | NS | NO scavenging | May contribute to the catechol group (3′, 4′-OH) of the B ring in the structure | [67] |
Pilosanol N | LPS/IFN-γ-induced RAW 264.7 macrophages | 25, 50, 100 μg/ml | IFN-γ and l-arginine | NS | NO production decreasing | iNOS↑and may also contribute to NF-κB/NO signaling disrupting | [67] |